<?xml version="1.0" encoding="UTF-8"?>
<p id="Par10">Exponential growth and advancement in technologies have provided rapid methods for the identification of infectious agents along with their genomes, microbial traits similarity and influence of host and viral factor on diseases chronicity [
 <xref ref-type="bibr" rid="CR23">23</xref>]. Globally, RT-PCR (real time polymerase chain reaction) technology have been used as standard diagnostic tool to detect nucleic acid (RNA) of SARS-CoV-2 from the nasal, throat swab or other samplings of COVID-19 patients [
 <xref ref-type="bibr" rid="CR24">24</xref>]. Furthermore, COVID-19 diagnosis through computed tomography (CT) scans using artificial intelligence tools help in differentiating community acquired pneumonia, other lung diseases and COVID-19 related lungs complications in rapid and accurate manner [
 <xref ref-type="bibr" rid="CR25">25</xref>]. Further verification could be done through sequencing technology.
</p>
